Skip to main content
abc-logo
  • Latest Articles
  • Diseases
    • Autoimmune Diseases
      • Arthritis
      • Crohn's Disease
      • Juvenile Arthritis
      • Lupus
      • Rheumatoid Arthritis
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Cancer
      • Destroying the Cancer Threat
      • Myeloma
      • Leukemia
      • Lymphoma
      • Breast Cancer
      • Cervical Cancer
      • Brain Cancer
      • Colon Cancer
      • Kidney Cancer
      • Stomach Cancer
      • Lung Cancer
      • Skin Cancer
    • Heart Diseases
      • Heart Transplant
      • Heart Disease
      • High Cholesterol
      • Obesity
    • Infectious Diseases
      • Coronavirus
      • HIV/AIDS
      • Hepatitis C
      • HPV
    • Mental Health
      • Depression
      • Schizophrenia
      • Bipolar Disorder
    • Neurological Diseases
      • Persevering to Power Brain Health Breakthroughs
      • ALS
      • Alzheimer's
      • Epilepsy
      • Migraine
      • Multiple Sclerosis
      • Parkinson's
    • Treatment Approaches
      • Genomics
      • Vaccines
      • Immunologic
      • Treatments
  • About Us
    • Our Commitment
      • Development Pipeline
      • Innovation Fragility
      • Innovation Offsets
      • Accessibility & Affordability
      • R&D Commitment
    • Faces of Innovation
      • Champions / Advocates
      • Patient Profiles
      • Researcher Profiles
    • Member Companies
      • Who We Are
    • Campaigns
      • Together
      • Do Not Go Gentle
      • New World
      • Cells
      • New Era of Medicine
    • Collaboration & Events
      • Events
  • SEARCH
  •  STAY AHEAD
  • Take Action
Hero Image Pattern 5
  1. Home
  2. About Us
  3. Faces of Innovation
  4. Patient Profiles
  5. I'm Not Going to Let My MS Diagnosis Get to Me

I'm Not Going to Let My MS Diagnosis Get to Me

Author: Laurel Katz

Patient Profiles
Multiple Sclerosis
Treatment Strategies
Champions / Advocates

Laurel Katz MS Patient image

Although most patients with multiple sclerosis (MS) are diagnosed between age 20 and 40, my story is a little different. After I got diagnosed with MS at age 53 and the doctors walked me through all my symptoms, we found out I had been walking around with undiagnosed MS for more than 30 years.

 

I freaked out. After researching this disease, the symptom that scared me the most is what they call one of the “silent symptoms,” which is impaired cognition. I really got worried that I wasn’t going to be able to focus and think – that this ability would decline with me.

 

But at the same time, I was relieved, because my diagnosis answered a lot of questions. Why am I so tired? Why am I losing my balance? Why am I dizzy, or why can’t I think straight?

MS is a rare disease where the immune system eats away at what protects our nerves. Affecting roughly 200,000 people each year, it’s a complicated disease to understand, and one that, currently, has no cure.

 

Living with MS can make each day unpredictable. Every morning when I wake up, I never know how much gas is going to be in my tank. Although I’ve had this disease for most of my life, it didn’t get severe enough to warrant a diagnosis until a few years ago when I began suffering from balance issues, tingling and fatigue. My doctors and I believe that menopause and age caused my MS to progress and become more noticeable.

 

I was so scared after my diagnosis, but things are better now. Thanks to advances in medicine, today you can live with MS and still lead a rewarding life. I am on a regimen of treatments that help manage my symptoms, and there is great support staff through the local National MS Society chapter in my community. I also credit my fighting ability to the support of family and friends. I volunteer at a local senior home because connecting with people and giving back gives me the strength I need to keep going.

 

The amount of new, approved therapies for MS in the five to six years since I’ve been diagnosed have been notable, and that tells me that scientists have been active researching my disease trying to find better, more effective therapies for controlling MS. Currently, there are 33 medicines in development for the treatment of MS.

Additionally, I’m grateful to the community of biopharmaceutical researchers developing treatments.

My glass was not always half-full, but now I’m looking back and seeing what it was like after my diagnosis, and the difference today is encouraging. I have decided that I’m not going to let my diagnosis get to me.

 

To me, MS is no longer anything to be afraid of.

GET THE LATEST IN INNOVATION NEWS

Subscribe to receive the latest in medical innovation, treatment insights, and inspirational stories.

SUBSCRIBE NOW

RELATED TOPICS

Patient Profiles
Multiple Sclerosis
Treatment Strategies
Champions / Advocates

Share:

  • #GoBoldly

Explore the innovative research and technological breakthroughs of America's biopharmaceutical industry, and get to know the people behind the fight to prevent, treat and cure disease.

abc-logo
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.

  • DISEASES
  • Cancer
  • Heart Diseases
  • Infectious Diseases
  • Autoimmune Diseases
  • Mental Health
  • Neurological Diseases
  • Treatment Approaches

  • Take Action

  • About Us
  • Collaboration & Events
  • Our Commitment
  • Member Companies
  • Campaigns
  • Faces of Innovation
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.